EUCTR2009-017581-22-DE进行中（未招募）不适用
Cognitive impairment in bipolar disorder treated with aripiprazole - CIBA
Department of Psychiatry and Psychotherapy, Charity University Medicine0 个研究点开始时间: 2010年12月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Bipolar Disorder (BP I + BP II)
- •Ethymic mood state since 6 months at least
- •Stable medication with mood stabilizers
- •Age > 18 y.
- •Cognitive Impairment measured on self reporting questionnaires
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Axis 1 condition other than bipolar disorder during last 6 month
- •organic brain disorder
- •pregnancy or breast feeding
研究者
相似试验
已完成
不适用
Enhancing cognition in bipolar disorderMental and Behavioural DisordersBipolar disorderISRCTN93360820Suffolk Mental Health Partnership NHS Trust (UK)20
招募中
2 期
Improvement of cognitive function in bipolar disorder by aripiprazole adjunct treatmentF31.7Bipolar affective disorder, currently in remissionDRKS00004316Bristol-Myers Squibb GmbH & Co. KGaA52
招募中
2 期
Riluzole in the control of obsession in bipolar patientsBipolar disorderIRCT20211118053093N4Shiraz University of Medical Sciences40
招募中
不适用
Psychiatric and cognitive function in patients with Neuroendocrine tumours with carcinoid syndrome.cognitieve stoornissencognitive impairment10027946depressionNL-OMON45631ederlands Kanker Instituut85
进行中（未招募）
1 期
Enhancing cognition in bipolar disorder - Enhancing cognition in bipolar disorderEUCTR2004-005010-37-GBSuffolk Mental Health Partnerships Trust20